1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsStudies Addressing Clinically Relevant Questions About Ketones and the Use of Continuous Ketone Monitoring in Type 1 Diabetes is sponsored by Breakthrough T1D. Supports research using continuous ketone monitoring to advance understanding and clinical management of type 1 diabetes, aiming to prevent complications and improve patient outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Breakthrough T1D Request for Applications: Studies addressing clinically relevant questions about ketones and the use of continuous ketone monitoring in type 1 diabetes by Breakthrough T1D | Atom Grants Breakthrough T1D Request for Applications: Studies addressing clinically relevant questions about ketones and the use of continuous ketone monitoring in type 1 diabetes Supports research using continuous ketone monitoring to advance understanding and clinical management of type 1 diabetes, aiming to prevent complications and improve patient outcomes.
Due Dates: November 12, 2025 (Letter of Intent) | January 21, 2026 (Full proposal) Funding Amounts: Up to $1,500,000 total over 3 years; larger budgets considered with strong justification. Summary: Supports research using continuous ketone monitoring to address clinically relevant questions and improve outcomes in type 1 diabetes.
This grant opportunity from Breakthrough T1D seeks studies that utilize continuous ketone monitoring (CKM) to address clinically relevant questions about ketone dynamics in type 1 diabetes (T1D). The aim is to leverage advanced CKM technology to gain new insights into T1D pathophysiology, improve prevention of diabetic ketoacidosis (DKA), and enhance the quality of life for people with T1D.
Research may explore the clinical significance of ketone patterns, integration of CKM with other diabetes management tools, educational strategies, and prediction or prevention of acute and long-term complications. Both interventional clinical trials and observational studies are supported, with an emphasis on innovative, clinically translatable findings. See the full grant listing
According to the current listing, eligibility includes: Academic and industry applicants are encouraged to apply; collaborative, cross-sector proposals are welcomed. Confirm the full requirements in the official notice before applying.
The current listing shows up to $1,500,000 total over 3 years; larger budgets considered with strong justification. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Studies Addressing Clinically Relevant Questions About Ketones and the Use of Continuous Ketone Monitoring in Type 1 Diabetes is funded by Breakthrough T1D. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
CDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleNIH's FY2026 omnibus adds a Phase IIB Strategic Breakthrough Award up to $30M — but it requires a 100% outside match. Here's who it's for and how to plan.
Read articleNSF's rebuilt SBIR/STTR program (NSF 26-510) pairs a $305,000 Phase I with a brand-new Strategic Breakthrough award worth up to $30 million for the strongest Phase II companies. The next Project Pitch deadline is July 27, 2026. Here is how the non-dilutive funding ladder now works, why the Project Pitch gate decides everything, and how a founder should sequence the next twelve months.
Read article